Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc News Story

$18.11 0.2  1.3%

Last Trade - 15/01/21

Sector
Healthcare
Size
Small Cap
Market Cap £259.6m
Enterprise Value £275.7m
Revenue £238k
Position in Universe 3633rd / 6547

BRIEF-Cellular Biomedicine Group Enters Into Definitive Merger Agreement

Wed 12th August, 2020 11:33am
Aug 12 (Reuters) - Cellular Biomedicine Group Inc  CBMG.O :
    * CELLULAR BIOMEDICINE GROUP (CBMG) ENTERS INTO DEFINITIVE
MERGER
AGREEMENT; TRANSACTION WOULD RESULT IN COMPANY GOING PRIVATE
    * CELLULAR BIOMEDICINE GROUP INC -  UNDER TERMS OF MERGER
AGREEMENT, CBMG WILL CONDUCT A 30-DAY "GO SHOP" PROCESS
    * CELLULAR BIOMEDICINE GROUP - CBMG'S STOCKHOLDERS WILL
RECEIVE
$19.75 IN CASH FOR EACH OUTSTANDING SHARE OF COMMON STOCK HELD
    * CELLULAR BIOMEDICINE GROUP INC - UPON CLOSING OF MERGER,
CBMG
WILL BECOME A WHOLLY OWNED SUBSIDIARY OF PARENT
    * CELLULAR BIOMEDICINE GROUP INC - MERGER IS NOT SUBJECT TO
A
FINANCING CONDITION
    * CELLULAR BIOMEDICINE GROUP -  TO BE ACQUIRED BY A
NEWLY-FORMED
ENTITY FORMED ON BEHALF OF A CONSORTIUM OF CEO AND CERTAIN OTHER
MEMBERS OF MANAGEMENT
    * CELLULAR BIOMEDICINE GROUP INC - ROLLOVER STOCKHOLDERS
COLLECTIVELY HOLD ABOUT 51.5% OF OUTSTANDING CBMG SHARES
    * CELLULAR BIOMEDICINE GROUP INC - CONSORTIUM ALSO CONSISTS
OF
DANGDAI INTERNATIONAL GROUP, MISSION RIGHT LIMITED, WEALTH MAP
HOLDINGS LIMITED
    * CELLULAR BIOMEDICINE GROUP INC -  CONSORTIUM ALSO MADE OF
YUNFENG FUND III, L.P., TF CAPITAL FUND III L.P., VELVET
INVESTMENT PTE. LTD.

Source text for Eikon:  ID:nPn7X7Sba 
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.